ARWR

ARWR

USD

Arrowhead Pharmaceuticals Inc. Common Stock

$16.740-0.430 (-2.504%)

Reaalajas hind

Healthcare
Biotehnoloogia
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$17.170

Kõrge

$17.490

Madal

$16.685

Maht

1.22M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

2.3B

Tööstusharu

Biotehnoloogia

Riik

United States

Kauplemisstatistika

Keskmine maht

1.84M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $9.57Praegune $16.740Kõrge $30.41

Seotud uudised

BusinessWire

Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-ALK7 for the Treatment of Obesity

ARO-ALK7 is the first investigational RNAi therapeutic to enter clinical studies that targets a gene expressed in adipose tissue Study initiation highlights Arrowhead's leadership in the delivery of siRNA to

Vaata rohkem
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-ALK7 for the Treatment of Obesity
BusinessWire

Arrowhead Pharmaceuticals to Participate in June 2025 Investor Conferences

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it is scheduled to participate in the following upcoming investor events: Jefferies Global Healthcare Conference – June 4-5, 2025 Type: Fireside

Vaata rohkem
Arrowhead Pharmaceuticals to Participate in June 2025 Investor Conferences
Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Arrowhead Pharma, Maintains $80 Price Target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Arrowhead Pharma with a Buy and maintains $80 price target.

Vaata rohkem
HC Wainwright & Co. Reiterates Buy on Arrowhead Pharma, Maintains $80 Price Target